ARTICLE | Clinical News
Sorafenib: Interim Phase III data
April 25, 2005 7:00 AM UTC
Interim data from an ongoing double-blind, placebo-controlled, international Phase III trial in >800 patients showed that sorafenib significant improved the progression-free survival in patients with ...